Evidence map›Paper›PMID 34135580›Full record

ArticleInternational journal of chronic obstructive pulmonary disease2021

Development and Validation of a Healthcare Utilization-Based Algorithm to Identify Acute Exacerbations of Chronic Obstructive Pulmonary Disease.

Douglas W Mapel, Melissa H Roberts, Susan Sama, Priyanka J Bobbili, Wendy Y Cheng, Mei Sheng Duh, Catherine Nguyen, Philippe Thompson-Leduc, Melissa K Van Dyke, Kieran J Rothnie and 5 more

Abstract read
In one paragraph

Article in International journal of chronic obstructive pulmonary disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Exacerbations and Healthcare Burden of COPD with Type 2 Inflammation: US Claims Analysis.International journal of chronic obstructive pulmonary disease · 2026
    Article
  5. Article
  6. Analysis of Current Status and Influencing Factors of Inhaler Treatment Adherence Among COPD Patients.International journal of chronic obstructive pulmonary disease · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. 20-year trends in excess costs of COPD.The European respiratory journal · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Douglas W Mapel *College of Pharmacy, University of New Mexico, Albuquerque, NM, USA.ORCID 0000-0001-5208-4363
Melissa H Roberts *College of Pharmacy, University of New Mexico, Albuquerque, NM, USA.ORCID 0000-0002-1314-4906
Susan SamaReliant Medical Group, Inc., Worcester, MA, USA.ORCID 0000-0003-0182-598x
Priyanka J BobbiliAnalysis Group, Inc., Boston, MA, USA.
Wendy Y ChengAnalysis Group, Inc., Boston, MA, USA.
Mei Sheng DuhAnalysis Group, Inc., Boston, MA, USA.ORCID 0000-0001-5035-6687
Catherine NguyenAnalysis Group, Inc., Boston, MA, USA.
Philippe Thompson-LeducAnalysis Group, Inc., Boston, MA, USA.ORCID 0000-0001-9047-3941
Melissa K Van DykeGlaxoSmithKline plc., London, UK.
Kieran J RothnieGlaxoSmithKline plc., London, UK.
Devi SundaresanReliant Medical Group, Inc., Worcester, MA, USA.
Julia M CertaKaiser Permanente Mid-Atlantic States (KPMAS), Mid-Atlantic Permanente Research Institute (MAPRI), Rockville, MD, USA.ORCID 0000-0002-0176-5019
Thomas S WhitingKaiser Permanente Mid-Atlantic States (KPMAS), Mid-Atlantic Permanente Research Institute (MAPRI), Rockville, MD, USA.
Jennifer L BrownKaiser Permanente Mid-Atlantic States (KPMAS), Mid-Atlantic Permanente Research Institute (MAPRI), Rockville, MD, USA.
Douglas W RoblinKaiser Permanente Mid-Atlantic States (KPMAS), Mid-Atlantic Permanente Research Institute (MAPRI), Rockville, MD, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are important events that may precipitate other adverse outcomes. Accurate AECOPD event identification in electronic administrative data is essential for improving population health surveillance and practice management. Objective: Develop codified algorithms to identify moderate and severe AECOPD in two US healthcare systems using administrative data and electronic medical records, and validate their performance by calculating positive predictive value (PPV) and negative predictive value (NPV). Methods: Data from two large regional integrated health systems were used. Eligible patients were identified using International Classification of Diseases (Ninth Edition) COPD diagnosis codes. Two algorithms were developed: one to identify potential moderate AECOPD by selecting outpatient/emergency visits associated with AECOPD-related codes and antibiotic/systemic steroid prescriptions; the other to identify potential severe AECOPD by selecting inpatient visits associated with corresponding codes. Algorithms were validated via patient chart review, adjudicated by a pulmonologist. To estimate PPV, 300 potential moderate AECOPD and 250 potential severe AECOPD events underwent review. To estimate NPV, 200 patients without any AECOPD identified by the algorithms (100 patients each without moderate or severe AECOPD) during the two years following the index date underwent review to identify AECOPD missed by the algorithm (false negatives). Results: The PPVs (95% confidence interval [CI]) for both moderate and severe AECOPD were high: 293/298 (98.3% [96.1-99.5]) and 216/225 (96.0% [92.5-98.2]), respectively. NPV was lower for moderate AECOPD (75.0% [65.3-83.1]) than for severe AECOPD (95.0% [88.7-98.4]). Results were consistent across both healthcare systems. Conclusion: This study developed healthcare utilization-based algorithms to identify moderate and severe AECOPD in two separate healthcare systems. PPV for both algorithms was high; NPV was lower for the moderate algorithm. Replication and consistency of results across two healthcare systems support the external validity of these findings.

Indexed as

Pulmonary Disease, Chronic ObstructiveAlgorithmsDatabases, FactualElectronic Health RecordsHumansInternational Classification of DiseasesPatient Acceptance of Health CareAECOPD eventsalgorithmclaims databaseelectronic medical recordspredictive valuesvalidation

Identifiers

PMID34135580
PMCPMC8200149

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.